Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurofilaments

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Living with Dementia

invisible disease1 - morphometry1 - multiple system atrophy1 - mci7 - calmeil1 - regular exercise1 - mid-life factors1 - alzheimers patients3 - diagnosis of ad1 - apolipoprotein e2 - encephalopathy-alcoholic10 - treatment for huntingtons disease1 - movement disorders1 - ftld4 - beta-amyloid protein1 - lewis and short1 - apoe43 - sleep loss1 - cognitive functions1 - astro-gliosis1 - examination of handwriting1 - dementia resistant1 - leeza gibbons1 - risk for dementia1 - impaired memory1 - dopaminergic neurons1 - physical discomfort1 - beta-blocker drugs1 - haldol1 - treat parkinson's1 -